09606 映恩生物－Ｂ
按盤價 
343.200 +4.600 (+1.359%) | 日期 | 股東名稱 | 披露原因 | 買入／賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 11/11/2025 | Morgan Stanley | 1305(L) | 62,000(L) | 4,587,937(L) 3,212,609(S) 0(P) | 5.19 3.63 0.00 | |
| 10/11/2025 | Morgan Stanley | 1306(L) | 600(L) | 4,572,642(L) 3,187,961(S) 0(P) | 5.17 3.61 0.00 | |
| 07/11/2025 | Morgan Stanley | 1305(L) | 73,600(L) | 4,515,380(L) 3,129,946(S) 0(P) | 5.11 3.54 0.00 | |
| 06/11/2025 | Morgan Stanley | 1305(L) | 186,796(L) | 4,591,380(L) 3,182,816(S) 0(P) | 5.20 3.60 0.00 | |
| 05/11/2025 | Morgan Stanley | 1306(L) | 274,496(L) | 4,625,717(L) 3,193,029(S) 0(P) | 5.23 3.61 0.00 | |
| 04/11/2025 | Morgan Stanley | 1306(L) | 267,500(L) | 4,837,017(L) 3,132,952(S) 0(P) | 5.49 3.55 0.00 | |
| 03/11/2025 | Morgan Stanley | 1311(L) | 100,000(L) | 4,983,901(L) 3,170,036(S) 0(P) | 5.66 3.60 0.00 | |
| 31/10/2025 | Morgan Stanley | 1305(L) | 72,386(L) | 4,948,855(L) 3,166,616(S) 0(P) | 5.62 3.59 0.00 | |
| 30/10/2025 | Morgan Stanley | 1305(L) | 52,722(L) | 4,903,737(L) 3,162,377(S) 0(P) | 5.57 3.59 0.00 | |
| 28/10/2025 | Morgan Stanley | 1306(L) | 155,800(L) | 4,956,353(L) 3,109,716(S) 0(P) | 5.62 3.53 0.00 | |
| 27/10/2025 | Morgan Stanley | 1305(L) | 67,400(L) | 5,112,567(L) 3,269,662(S) 0(P) | 5.80 3.71 0.00 | |
| 24/10/2025 | Morgan Stanley | 1213(L) | -1,420,010(L) | 5,112,567(L) 3,269,662(S) 0(P) | 5.80 3.71 0.00 | |
| 24/10/2025 | Morgan Stanley | 1305(L) | 863,900(L) | 6,532,577(L) 3,110,458(S) 0(P) | 7.42 3.53 0.00 | |
| 23/10/2025 | Morgan Stanley | 1305(L) | 34,700(L) | 6,706,789(L) 3,175,467(S) 0(P) | 7.61 3.60 0.00 | |
| 22/10/2025 | Morgan Stanley | 1306(L) | 126,500(L) | 6,668,978(L) 3,086,279(S) 0(P) | 7.57 3.50 0.00 | |
| 21/10/2025 | Morgan Stanley | 1013(L) | +4,525,234(L) | 6,668,978(L) 3,086,279(S) 0(P) | 7.57 3.50 0.00 | |
| 21/10/2025 | 朱忠远 | 1313(L) 14015(S) | 2,599,800(L) 2,599,800(S) | 16,026,123(L) 2,599,800(S) | 18.20 2.95 | |
| 21/10/2025 | DualityBio Ltd. | 1313(L) 14015(S) | 2,599,800(L) 2,599,800(S) | 6,500,000(L) 2,599,800(S) | 7.38 2.95 | |
| 17/10/2025 | LAV Fund VI, L.P. | 1201(L) | -3,398,800(L) | HKD277.550(L) | 7,873,521(L) | 8.94 |
| 17/10/2025 | LAV GP VI, L.P. | 1201(L) | -3,398,800(L) | HKD277.550(L) | 7,873,521(L) | 8.94 |
| 17/10/2025 | 施毅 | 1201(L) | -5,030,300(L) | HKD277.550(L) | 11,652,921(L) | 13.24 |
| 17/10/2025 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -5,030,300(L) | HKD277.550(L) | 11,652,921(L) | 13.24 |
| 17/10/2025 | LAV Fund VI Opportunities, L.P. | 1201(L) | -1,631,500(L) | HKD277.550(L) | 3,779,400(L) | 4.29 |
| 17/10/2025 | LAV GP VI Opportunities, L.P. | 1201(L) | -1,631,500(L) | HKD277.550(L) | 3,779,400(L) | 4.29 |
| 17/10/2025 | LAV Corporate VI GP Opportunities, Ltd. | 1201(L) | -1,631,500(L) | HKD277.550(L) | 3,779,400(L) | 4.29 |
| 17/10/2025 | Morgan Stanley | 1704(L) | -5,142,988(L) | 2,019,634(L) 503,858(S) 0(P) | 2.29 0.57 0.00 | |
| 17/10/2025 | LAV Corporate VI GP, Ltd. | 1201(L) | -3,398,800(L) | HKD277.550(L) | 7,873,521(L) | 8.94 |
| 16/10/2025 | King Star Med LP | 1201(L) | -670,000(L) | HKD311.240(L) | 5,739,554(L) | 6.52 |
| 16/10/2025 | Morgan Stanley | 1312(L) | 34,300(L) | 7,068,843(L) 443,864(S) 0(P) | 8.02 0.50 0.00 | |
| 15/10/2025 | Morgan Stanley | 1013(L) | +6,358,687(L) | 7,068,843(L) 443,864(S) 0(P) | 8.02 0.50 0.00 | |
| 09/05/2025 | 施毅 | 1213(L) | 16,683,221(L) | 16,683,221(L) | 18.95 | |
| 09/05/2025 | 朱忠远 | 1312(S) | -2,599,800(S) | 16,026,123(L) 0(S) | 18.20 0.00 | |
| 09/05/2025 | LAV Fund VI, L.P. | 1213(L) | 11,272,321(L) | 11,272,321(L) | 12.80 | |
| 09/05/2025 | LAV Corporate VI GP, Ltd. | 1213(L) | 11,272,321(L) | 11,272,321(L) | 12.80 | |
| 09/05/2025 | LAV GP VI, L.P. | 1213(L) | 11,272,321(L) | 11,272,321(L) | 12.80 | |
| 09/05/2025 | DualityBio Ltd. | 1312(S) | -2,599,800(S) | 6,500,000(L) 0(S) | 7.38 0.00 | |
| 09/05/2025 | LAV Asset Management (Hong Kong) Limited | 1213(L) | 16,683,221(L) | 16,683,221(L) | 18.95 | |
| 15/04/2025 | DualityBio Ltd. | 1701(L) 1313(S) | 6,500,000(L) +2,599,800(S) | 6,500,000(L) 2,599,800(S) | 7.61 3.04 | |
| 15/04/2025 | LAV Corporate VI GP Opportunities, Ltd. | 1701(L) | 5,410,900(L) | 5,410,900(L) | 6.33 | |
| 15/04/2025 | LAV Fund VI, L.P. | 1701(L) | 11,272,321(L) | 11,272,321(L) | 13.19 | |
| 1 2 | ||||||
| 備註： | (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。 |
| (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 17/11/2025 18:00 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
